Okay, let's tackle this question about the major source of collagen in cirrhosis. The user wants a detailed explanation for an MCQ. First, I need to recall what's happening in liver cirrhosis regarding collagen deposition.

So, cirrhosis involves fibrosis where excessive extracellular matrix is deposited. The main cell type involved in liver fibrosis is the hepatic stellate cells (HSCs). When activated, HSCs transform into myofibroblasts, which produce collagen, especially type I and III. That's the core concept here.

The correct answer should be hepatic stellate cells. Now, the options A to D probably include other cell types. Let me think of common distractors. Kupffer cells are macrophages involved in phagocytosis, not collagen production. Hepatocytes are the main liver cells but don't produce collagen in fibrosis. Myofibroblasts are a result of HSC activation but are not the source per se. Portal fibroblasts might also be an option but are less significant than HSCs.

For the clinical pearl, it's important to remember that targeting HSCs is key in antifibrotic therapies. The high-yield fact is that HSCs are the primary collagen producers in liver cirrhosis. Need to make sure the explanation is concise and covers all the required sections without exceeding the character limit. Also, check that each section is properly formatted with bold labels and no markdown beyond that. Alright, let's structure this step by step.

**Core Concept**
In liver cirrhosis, excessive collagen deposition results from activated hepatic stellate cells (HSCs), which transition into myofibroblasts. This process is central to fibrosis, driven by chronic injury and inflammation. **Collagen type I and III** are the primary extracellular matrix components produced.

**Why the Correct Answer is Right**
Hepatic stellate cells (HSCs) are the principal source of collagen in cirrhosis. Upon activation by cytokines (e.g., TGF-β), HSCs lose vitamin A storage and proliferate, secreting collagen and other matrix proteins. This fibrogenic response is exacerbated by persistent inflammation, leading to scar formation and architectural distortion in the liver.

**Why Each Wrong Option is Incorrect**
**Option A:** Kupffer cells (liver macrophages) mediate inflammation and phagocytosis, not collagen production.
**Option B:** Hepatocytes synthesize most plasma proteins but do not contribute to fibrosis.
**Option D:** Portal fibroblasts may contribute minimally but are outcompeted by HSCs as the dominant collagen source.

**Clinical Pearl / High-Yield Fact**
Targeting HSC activation is a key therapeutic strategy in antifibrotic drug development. Remember: **HSCs = "quiescent vitamin A-storing cells → activated collagen-secreting myofibroblasts"** in cirrhosis.

**Correct Answer: C. Hepatic stellate cells**

✓ Correct Answer: B. Ito cell (Hepatic stellate cell)